Header

UZH-Logo

Maintenance Infos

Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus


Wuerzner, G; Muller, O; Erne, P; Cook, S; Sudano, I; Luscher, T F; Noll, G; Kaufmann, U; Rickli, H; Waeber, B; Kaiser, C; Sticherling, C; Pechere-Bertschi, A; Baumgartner, I; Jacob, A L; Burnier, M; Qanadli, S D (2014). Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus. Swiss Medical Weekly, 144:w13913.

Abstract

Transcatheter (or percutaneous) renal denervation is a novel technique developed for the treatment of resistant hypertension. So far, only one randomised controlled trial has been published, which has shown a reduction of office blood pressure. The Swiss Society of Hypertension, the Swiss Society of Cardiology, The Swiss Society of Angiology and the Swiss Society of Interventional Radiology decided to establish recommendations to practicing physicians and specialists for good clinical practice. The eligibility of patients for transcatheter renal denervation needs (1.) confirmation of truly resistant hypertension, (2.) exclusion of secondary forms of hypertension, (3.) a multidisciplinary decision confirming the eligibility, (4.) facilities that guarantee procedural safety and (5.) a long-term follow-up of the patients, if possible in cooperation with a hypertension specialist. These steps are essential until long-term data on safety and efficacy are available.

Abstract

Transcatheter (or percutaneous) renal denervation is a novel technique developed for the treatment of resistant hypertension. So far, only one randomised controlled trial has been published, which has shown a reduction of office blood pressure. The Swiss Society of Hypertension, the Swiss Society of Cardiology, The Swiss Society of Angiology and the Swiss Society of Interventional Radiology decided to establish recommendations to practicing physicians and specialists for good clinical practice. The eligibility of patients for transcatheter renal denervation needs (1.) confirmation of truly resistant hypertension, (2.) exclusion of secondary forms of hypertension, (3.) a multidisciplinary decision confirming the eligibility, (4.) facilities that guarantee procedural safety and (5.) a long-term follow-up of the patients, if possible in cooperation with a hypertension specialist. These steps are essential until long-term data on safety and efficacy are available.

Statistics

Citations

Altmetrics

Downloads

23 downloads since deposited on 14 May 2014
7 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2014
Deposited On:14 May 2014 08:58
Last Modified:05 Apr 2016 17:50
Publisher:EMH Swiss Medical Publishers
ISSN:0036-7672
Additional Information:Wuerzner, Gregoire Muller, Olivier Erne, Paul Cook, Stephane Sudano, Isabella Luscher, Thomas F Noll, Georg Kaufmann, Urs Rickli, Hans Waeber, Bernard Kaiser, Christophe Sticherling, Christian Pechere-Bertschi, Antoinette Baumgartner, Iris Jacob, Augustinus L Burnier, Michel Qanadli, Salah D Research Support, Non-U.S. Gov't Switzerland Swiss medical weekly Swiss Med Wkly. 2014 Mar 20;144:w13913. doi: 10.4414/smw.2014.13913.
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.4414/smw.2014.13913
Official URL:http://www.ncbi.nlm.nih.gov/pubmed/24652665

Download

Preview Icon on Download
Preview
Content: Published Version
Filetype: PDF
Size: 611kB
View at publisher